Name: General Counsel Forum, ACC-Minnesota 2016 | Fish
Start: 2016-09-29T13:00

Why Fish

Diversity, Equity & Inclusion

Pro Bono

Partner Organizations

Legal Operations

Pricing

Legal Project Management

Knowledge Management

eDiscovery

Legal Technology Services

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Appellate

Chancery & Corporate Governance

Post-Grant

Inter Partes Review

Post-Grant Review

Ex Parte Reexamination

Supplemental Examination

Patent

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Industries

Electrical & Computer Technology

Artificial Intelligence

Digital Health

Digital Media & E-Commerce

Financial, Business & FinTech Services

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Post-Grant Annual Reports

Fish is proud to be a Platinum Sponsor ofthe Minnesota ACC’sGeneral Counsel Forum. For more information about the event, please click here.

General Counsel Forum, ACC-Minnesota 2016

PLI Patenting Blockchain and Distributed Ledger Technologies 2023

Minnesota Patent Litigation Wrap-Up: Q3 2023

ITC Monthly Wrap-Up: October 2023

Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

Texas Patent Litigation Monthly Wrap-Up: October 2023

District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit

ITC Monthly Wrap-Up: September 2023

Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.

ITC Monthly Wrap-Up: August 2023

Minnesota Patent Litigation Wrap-Up: Q2 2023